Personal profile
Education
- 2010.09-2020.06 Ph.D. Degree, Graduate Institute of Clinical Medicine, National Cheng Kung University, Taiwan
- 2007.09-2010.01 Master Degree, Graduate Institute of Clinical Medicine, National Cheng Kung University, Taiwan
- 1994.09-2001.06 Medical Degree, School of Medicine, China Medical University, Taiwan
Experience
- 2026.02- Associate Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2024.08- Director, Taipei Cancer Center-Gastric Cancer, Taipei Medical University
- 2024.08- Director, Division of General Surgery, Department of Surgery, Taipei Municipal Wanfang Hospital
- Director, Minimally Invasive and Robotic Surgery Center, Taipei Municipal Wanfang Hospital
- Member, Comprehensive Care Center for Patients with Peritoneal Metastasis, Taipei Municipal Wanfang Hospital
- 2021.01-2026.01 Assistant Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2017.12-2024.07 Director, Trauma & Emergency Surgery, Department of Surgery, Taipei Municipal Wanfang Hospital
- 2016.01- Attending Surgeon, Division of General Surgery and Chief, Division of Trauma and Emergency Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taiwan.
- 2016.10-2017.09 Visiting Surgeon, Peritoneal Dissemination Center, Kishiwada Tokushukai Hospital, Kishiwada City, Osaka, Japan
- 2012.09-2015.12 Attending Surgeon and Chief, Division of General Surgery, Department of Surgery, Tainan Municipal Hospital, Taiwan
- 2008.08-2012.08 Instructor and Attending Surgeon, Department of Surgery, National Cheng Kung University Hospital-Tainan and Dou-Liou Branch, College of Medicine, National Cheng Kung University, Taiwan
Awards
- Research Award:
- 2009 The Travel Grant of 46th Annual Meeting of Japanese Society for Surgical Metabolism and Nutrition (Japan)
- 2013 International federation for the Surgery of Obesity and Metabolic Disorders
- (IFSO) Asia Pacific Chapter Meeting – TOP SEVEN PAPAERS AWARDS
Research Interests
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
- Digestive surgery
- Hepatobiliary Surgery
- Laparoscopic and Robotic Surgery
- Breast surgery
- Surgical Oncology
Related Link
- https://www.researchgate.net/profile/Hsin-Hsien_Yu
Fingerprint
Dive into the research topics where Hsin-Hsien Yu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Exploring the potential of UBR5-MOAP1 as a therapeutic target for signet-ring cell gastric cancer
Yu, H.-H. (PI)
5/1/26 → 4/30/27
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
To investigate the anti-gastric cancer effects and molecular mechanisms of eribulin combined with ERK1/2 and Akt inhibitors using human gastric cancer cell lines and gastric cancer patient-derived tumor organoids
Yu, H.-H. (PI)
1/1/26 → 12/31/26
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
The molecular impacts of stress hormones on chemosensitivity of gastric cancer cells
Yu, H.-H. (PI)
1/1/25 → 9/30/26
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
Utilizing gastric cancer cell lines and organoids to investigate the association and underlying mechanisms of lipid droplets and chemosensitivity
Yu, H.-H. (PI)
5/1/25 → 4/30/26
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
A multifaceted evaluation the pharmacological inhibition of hedgehog as a therapeutic strategy for gastric cancer
Yu, H.-H. (PI)
5/1/24 → 4/30/25
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Chemotherapy elevates cell surface PD-L1 and MHC-I expression in apoptotic gastric cancer cells
Lou, Y. S., Liu, X. C., Cheng, C. C., Yin, Y. H., Chien, T. C., Hsu, P. L., Lee, C. W., Yu, H. H. & Su, B. C., 2025, In: International Journal of Immunopathology and Pharmacology. 39, 03946320251338662.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Hyperthermia-induced cytotoxicity and modulation of PD-L1 and MHC-I expression in human non-small cell lung cancer cell lines
Tu, Y. C., Yeh, W. C., Fang, Y. W., Lo, K. H., Liang, L. N., Liu, X. C., Tsai, C. C., Cheng, C. C., Lin, M. C., Yu, H. H. & Su, B. C., 2025, In: Experimental Physiology.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Citations (Scopus) -
Vismodegib Potentiates Marine Antimicrobial Peptide Tilapia Piscidin 4-Induced Cytotoxicity in Human Non-Small Cell Lung Cancer Cells
Yeh, W. C., Tu, Y. C., Chien, T. C., Hsu, P. L., Lee, C. W., Wu, S. Y., Pan, B. S., Yu, H. H. & Su, B. C., Oct 2025, In: Probiotics and Antimicrobial Proteins. 17, 5, p. 3247-3257 11 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Antihypertensive agent losartan promotes tongue squamous cell carcinoma cell proliferation via EGFR/ERK1/2/cyclin D1 signaling axis
Wu, L. Y., Su, B. C., Yu, H. H., Cheng, C. C., Tsai, C. C., Hsu, P. L. & Lee, C. W., Dec 2024, In: Journal of Oral Biosciences. 66, 4, p. 74-80 7 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Combination of Vismodegib and Paclitaxel Enhances Cytotoxicity via Bak-mediated Mitochondrial Damage in EGFR-Mutant Non-Small Cell Lung Cancer Cells
Yeh, W. C., Tu, Y. C., Hsu, P. L., Lee, C. W., Yu, H. H. & Su, B. C., Dec 2024, In: Cell Biochemistry and Biophysics. 82, 4, p. 3499-3506 8 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus)